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Abstract
This study examines whether incorporating cholesterol-loaded methyl-β-cyclodextrin (CLC)
in the bovine oocyte plasma membrane improves oocyte tolerance to vitrification. In vitro
matured oocytes were incubated with 2 mg/ml BODIPY-labeled CLC for different time inter-
vals in FCS or PVA supplemented medium or exposed to different CLC concentrations to
examine the subcellular localization of cholesterol by confocal microscopy live-cell imaging.
Subsequently, the effects of optimized CLC concentrations and incubation times prior to vit-
rification on early embryo development were assessed. Then, we evaluated the effects of
pretreatment with 2 mg/ml CLC for 30 min before the vitrification of immature (GV) and in
vitro matured (MII) oocytes on developmental competence and gene expression. Our
results indicate a high plasma membrane labeling intensity after 30 min of incubation with 2
mg/ml CLC for 30 min, regardless of the holding medium used. When oocytes were incu-
bated with 1 mg/ml, 2 mg/ml and 3 mg/ml of CLC, intense labeling was observed at the
plasma membrane after 40, 30 and 20 min, respectively. CLC pre-treatment before the vitri-
fication of bovine oocytes did not affect subsequent cleavage and embryo development
rates irrespective of CLC concentrations, incubation times or meiotic stage. However, pre-
treatment seems to improve the quality of embryos derived from vitrified oocytes, mainly
when oocytes were vitrified at the GV stage.
Introduction
Widespread use of animal oocytes for procedures such as in vitro embryo production, nuclear
transfer or gene banking has dramatically increased interest in oocyte cryopreservation in the
agricultural and scientific communities [1]. The practical benefits of vitrification to preserve
bovine oocytes are nevertheless limited since vitrified oocytes show impaired in vitro matura-
tion and early embryo development.
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During oocyte cryopreservation, cooling and osmotic stress can cause irreversible damage
to membrane integrity [2, 3]. Oocytes undergo substantial volume changes due to water and
cryoprotectant movement during cryopreservation (reviewed in: [4]). This suggests that cells
with more flexible membranes permeable to water and cryoprotectants are likely to suffer less
damage that those with more rigid, less permeable membranes. The incorporation of choles-
terol in the plasma membrane should enhance membrane fluidity and permeability at low
temperatures, and thereby increase oocyte tolerance to cryopreservation.
Cyclodextrins (CDs) are cyclic oligosaccharides consisting of five or more α-D-glucopyra-
nose residues linked by α-1,4 glucosidic bonds that have a hydrophobic center capable of inte-
grating lipids. The high affinity of βCDs for cholesterol, besides conferring the capacity to
remove cholesterol from biological membranes, also enables the formation of cholesterol
inclusion complexes that donate cholesterol to the membrane. The efficiency of cholesterol
transfer from βCD inclusion complexes to biological membranes depends on the βCD:choles-
terol molar ratio, βCD-cholesterol concentration, and treatment duration [5, 6].
In prior work in oocytes it was observed that the co-incubation of bovine immature [7] or
in vitro-matured [8] oocytes with βCDs loaded with cholesterol (CLC) improved the nuclear
maturation of oocytes after vitrification, but did not benefit embryo development to the blasto-
cyst stage. These authors attributed the lack of effect of CLC treatment in improving cryotoler-
ance that cholesterol was preferentially transferred to lipids or proteins present in the fetal calf
serum (FCS) avoiding its incorporation into the oocyte. When examining the incorporation of
cholesterol in the oocyte plasma membrane after incubation with CLC, Horvath and Seidel [8]
and Jime´nez-Trigos et al [9] observed that cholesterol was transported through the cumulus
layers and the zona pellucida into the oocyte. However, little information was provided regard-
ing the exact localization of cholesterol within the oocyte or how much cholesterol entered the
cell. Boron-dipyrromethene (BODIPY)-cholesterol BODIPY-cholesterol has been used as a
cholesterol probe in model membranes and in trafficking studies in living cells [10, 11].
Through in vivo time-lapse analysis, the time-point at which this probe was located at the
plasma membrane of mouse oocytes has been identified [12]. We therefore hypothesized that
this new fluorescent cholesterol probe would be useful to determine the dose and incubation
time at which cholesterol locates mainly at the plasma membrane of bovine oocytes before
vitrification.
Previous studies have shown that basic cryobiological differences exist between immature
and mature oocytes. Mature metaphase II-stage (MII) oocytes can be difficult to cryopreserve,
mainly because of the presence of the meiotic spindle and chromosome configuration. By con-
trast, in immature germinal vesicle-stage (GV) oocytes, spindle depolymerization during cryo-
preservation is avoided but oocytes at GV stage aremore sensitive to osmotic stress than MII
oocytes [13]. Therefore, the improvement in membrane fluidity conferred by membrane cho-
lesterol enrichment has strong potential to enhance tolerance of GV oocytes to vitrification.
The present study was designed to examine whether exposure of bovine oocytes to CLC
before vitrification/warming could improve their cryotolerance and embryo development
after in vitro fertilization. In a first set of experiments, we characterized intracellular trafficking
and localization of fluorescently-labeled cholesterol in in vitro matured oocytes incubated with
CLC either in FCS or PVA supplemented medium and assessed their effect on early embryo
development after vitrification/warming. In a second set of experiments, different concentra-
tions of CLC were compared in terms of the subcellular localization of fluorescently-labeled
cholesterol. Subsequently, the effects of optimized CLC concentrations and incubation times
prior to vitrification on early embryo development were assessed. Finally, immature or in vitro
matured oocytes were vitrified after 30 min of incubation with 2 mg/ml CLC, and then fertil-
ized and cultured to determine early embryo development and quality, and at the level of
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expression of specific genes that are potentially important in embryo survival. The expression
patterns of genes involved in apoptosis (BAX), lipid metabolism (CYP51), imprinting
(DNMT3A, IGF2R, UBE2A), heat (HSPA1A) and oxidative stress (MnSOD) were determined
on Day 5 morulae by RT-qPCR.
Material and methods
Chemicals and supplies
All chemicals and reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA)
unless otherwise stated.
Bovine oocyte collection and in vitro maturation
The methods used for the in vitro maturation of the bovine oocytes have been described else-
where [14]. Briefly, bovine ovaries were collected at slaughter from a local abattoir (Escorxador
Sabadell, S.A., Sabadell, Spain) and transported to the laboratory in phosphate buffered saline
(PBS) at 35–37˚C. Cumulus oocyte complexes (COCs) were obtained by aspirating 2–10 mm
follicles. Only COCs with three or more layers of cumulus cells and a homogeneous cytoplasm
were selected to be matured in vitro. After three washes in modified PBS (PBS supplemented
with 36 mg/ml pyruvate, 50 mg/ml gentamicin and 0.5 mg/ml bovine serum albumin (BSA)),
groups of up to 50 COCs were placed in 500 μl of maturation medium in four-well plates and
cultured for 24 h at 38.5˚C in a 5% CO2 humidified air atmosphere. The maturation medium
was comprised of TCM-199 supplemented with 10% (v/v) FCS, 10 μg/ml epidermal growth
factor and 50 mg/ml gentamicin.
Cholesterol-loaded methyl-β-cyclodextrin (CLC)
The method described by Purdy and Graham [15] was used to prepare CLC. Briefly, 1 g of
methyl-β-cyclodextrin was dissolved in 2 ml of methanol by vortexing. Separately, 200 mg cho-
lesterol was dissolved in 1 ml of chloroform. A 0.45 ml aliquot of the cholesterol solution was
then gently mixed with the 2 ml of cyclodextrin solution until combined to form a clear solu-
tion. The solvents were removed from the mixture with a stream of nitrogen gas and the crys-
tals obtained were dried for 24 h, stored at room temperature, and designated cholesterol-
loaded methyl-β-cyclodextrin (CLC).
Cholesterol imaging in living bovine oocytes treated with CLC
To determine cholesterol trafficking, oocytes were incubated together with different concen-
trations of CLC (see experimental design) complexed with 1 μM BODIPY-cholesterol (BPY--
Chol. Avanti Polar Lipids, Alabama, USA) [12, 16] at 38.5˚C and 5% CO2 in air. BPY-Chol
was visualized in living oocytes using a confocal microscope Leica TCS SP5 (Leica Microsys-
tems GmbH, Mannheim, Germany). BPY-Chol was excited with a 488 nm argon laser with
fluorescence emission detected in the 500–620 nm range using a HyD detector to identify the
intracellular location of the fluorescent probe after incubation at different chase times (see
experimental design).
The fluorescence intensity of plasma membrane and cytoplasm was quantified using ImageJ
Software. After subtracting the background, cytoplasm mean intensity was measured by man-
ually outlining the area corresponding to the oocyte cytoplasm, excluding the plasma mem-
brane. A 55-pixel band was then created to surround the plasma membrane and mean
fluorescence intensity for the plasma membrane was determined. The images were segmented
into foreground and background by setting a threshold that was the same for all samples.
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Oocyte vitrification and warming
Vitrification protocol. The vitrification/warming procedures employed were essentially
as described by Morato´ et al. [17]. The holding medium (HM) used to formulate the vitrifica-
tion-warming solutions consisted of HEPES-TCM-199 supplemented with 20% (v/v) FCS. All
steps were performed under a laminar flow hood heated to 38.5˚C using a stereomicroscope to
visualize each step. Partially denuded oocytes were transferred into equilibration solution (ES)
consisting of 7.5% (v/v) ethylene glycol (EG) and 7.5% (v/v) dimethylsulfoxide (DMSO) in
HM for 10 min. Subsequently, oocytes were moved to the vitrification solution (VS) contain-
ing 15% (v/v) DMSO, 15% (v/v) EG and 0.5 M sucrose dissolved in HM. After incubating for
30–40 s, oocytes were loaded onto a cryotop. Almost all the solution was removed to leave only
a thin layer covering the oocytes and the cryotop plunged into liquid nitrogen. The entire pro-
cess from exposure to VS to plunging in liquid nitrogen was completed in 90 seconds. When
synthetic medium was required (see experimental design), 6% polyvinylpyrrolidone (PVP) (w/
v) and 1 mg/ml fetuin were added to the equilibration and vitrification solutions instead of
FCS.
Warming protocol. Vitrified oocytes were warmed by directly immersing the cryotop
into the warming solution containing 1 M sucrose dissolved in HM for 1 min. Next, the recov-
ered oocytes were transferred to the dilution solution containing 0.5 M sucrose dissolved in
HM for 3 min. The oocytes were then incubated in HM for 5 min. After a final rinse in HM
for 1 min, oocytes were transferred to the maturation medium and allowed to complete their
in vitro maturation.
In vitro fertilization and embryo culture
In vitro matured oocytes (fresh and vitrified/warmed) were in vitro fertilized at 38.5˚C in a 5%
CO2 atmosphere. Frozen–thawed spermatozoa from Asturian bulls (ASEAVA, Llanera, Astu-
rias, Spain) of proven fertility were used in all the experimental procedures. Motile spermato-
zoa were obtained by centrifuging frozen–thawed sperm on a discontinuous gradient
(Bovipure, Nidacon International, Gothenburg, Sweden) for 10 min at 100×g at room temper-
ature. Viable spermatozoa collected from the bottom were washed (Boviwash, Nidacon Inter-
national, Gothenburg, Sweden) and pelleted by centrifugation at 100×g for 5 min.
Spermatozoa were counted in a Neubauer hemocytometer and diluted in an appropriate vol-
ume of fertilization medium (Tyrode’s medium supplemented with 25 mM bicarbonate, 22
mM Na-lactate, 1 mM Na-pyruvate, 6 mg/ml fatty acid-free BSA and 10 mg/ml heparin–
sodium salt (Calbiochem, Darmstadt, Germany)) to a final concentration of 1 × 106 spermato-
zoa/ml. 100-μl droplets of diluted sperm were prepared under mineral oil and 20 to 25
oocytes/droplet co-incubated at 38.5˚C, in a 5% CO2 high humidity atmosphere.
After 18–20 h, presumptive zygotes were stripped of remaining cumulus cells by gentle vor-
texing after which they were cultured in 100-μl drops of synthetic oviductal fluid (SOF) [18]
containing FCS (5%, v/v) under mineral oil at 38.5˚C in 5% CO2, 5% O2, 90% N2 for 8 days.
Cleavage rates were recorded at 48 h post-insemination (hpi) and the number of blasto-
cysts was determined on Days 7 and 8 post-insemination (pi). Day 8 embryos were classified
according to the degree of blastocele expansion into three groups according to Morato´ et al.
[19]: (1) non-expanded blastocysts, in which the blastocele volume was less than one-half of
the total volume of the blastocyst; (2) expanded blastocysts, in which the blastocele volume
was more than one-half of the total volume of the blastocyst; (3) hatched or hatching blasto-
cysts, in which the expanded blastocyst was without a zona pellucida or had an opened zona
pellucida.
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RNA extraction and real-time quantitative (rt)-PCR
Total RNA was extracted from Day-5 morulae using the Picopure RNA extraction Kit
(Thermo Fisher Scientific Inc, Waltham, MA, USA) following the manufacturer’s instructions.
Morulae harvested from each experimental group were pooled in groups (10 morulae) and
washed three times in Dulbecco’s-PBS at 38.5˚C. Each pool was added to 100 μl of extraction
buffer, snap frozen in liquid nitrogen, and stored at– 80˚C until RNA isolation. A total of five
pools for each experimental group were analyzed.
For RNA extraction, samples were vortexed for 15 s and incubated with lysis solution at
42˚C for 30 min. The samples were then centrifuged at 3,000×g for 3 min. The upper aqueous
phase containing RNA was carefully transferred to a new tube without disturbing the interface.
RNA was precipitated by the addition of an equal volume of 70% ethanol and loaded onto a
spin column from a PicoPure™ RNA Isolation kit (Arcturus, Mountain View, CA, USA)
according to the manufacturer’s instructions. RNA concentrations were determined using a
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies Inc., Wilmington, USA).
Total RNA (40 ng) was reverse-transcribed to produce cDNA using Multiscribe™ Reverse
Transcriptase (Applied biosystems, Foster City, CA, USA) primed with random primers. In all
cases, a reverse transcriptase negative control was used to evaluate genomic DNA contamina-
tion. The relative abundance of mRNA transcripts was calculated using the ΔΔcq method with
the conserved helix-loop-helix ubiquitous kinase (CHUK) (Falco et al., 2006) as a reference
gene on a Bio-Rad CFX Connect™ Real-Time PCR Detection System (Bio-Rad Laboratories
Inc, Mississaugua, Canada) and QuantiFast SYBR Green PCR Master Mix (Qiagen, Toronto,
Canada). The genes analyzed included BAX, CYP51,DNMT3A, IGF2R, UBE2A,HSPA1A and
MnSOD, along with the reference gene. In each sample, cDNA was analyzed in quadruplicate
to determine relative levels of each transcript of interest. In all cases, a reverse transcriptase
negative control was included. The qRT-PCR reaction mix contained 12.5 μl 2× QuantiFast
SYBR Green PCR Master Mix, 2μl (1875 nM) forward and reverse primers (Integrated DNA
Technologies, Inc., IA, USA) specific for the genes of interest and 2 μl of cDNA template. The
final volume was made up to 25 μl using nuclease-free water. Reactions were run at 95˚C for 5
min followed by 40 cycles of 95˚C for 10 s and 60˚C for 1 min and a standard dissociation
curve.
Primer sequences and approximate sizes of the amplified fragments of all transcripts are
provided in Table 1. The efficiency of primer amplification was 90 to 100%. Non-template
controls were not amplified or returned a Cq value 10 points higher than the average Cq for
the genes. Expression levels of the target genes were normalized to average expression levels of
the CHUK gene, which was expressed at constant levels (Cq values) in all samples and was sta-
ble under the conditions used.
Experimental design
Experiment 1. Characterize the effects of CLC added to a FCS-supplemented or chemi-
cally-defined medium before vitrification on in vitro matured bovine oocytes.
Experiment 1a: Live-cell imaging of cholesterol transport within in vitro matured bovine
oocytes incubated with CLC in a FCS-supplemented or chemically-defined medium.
After 22 h of IVM, oocytes were denuded by gentle pipetting and incubated in 2 mg/ml
BODIPY-labeled CLC at 38.5˚C in HEPES-TCM-199 medium containing either 10% (v/v)
FCS or 0.05% (w/v) PVA. BPY-Chol fluorescence was visualized in living oocytes at 30, 45, 60
and 75 min using a confocal microscope. A total of 20 oocytes were examined in each group in
3 different replicates.
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Experiment 1b: Effects of CLC added to FCS-supplemented or chemically-defined medium
before vitrification on the developmental competence of in vitro matured oocytes.
After 22 h of IVM and according to the results obtained in the previous experiment, par-
tially denuded oocytes were randomly distributed into five groups: A and C) oocytes main-
tained in medium containing FCS; B) oocytes incubated in medium containing FCS with 2
mg/ml CLC; D) oocytes incubated in medium containing PVA with 2 mg/ml CLC; and E)
oocytes incubated in medium containing PVA without CLC. Incubation with or without CLC
was carried out at 38.5˚C in 5% CO2 for 30 min. Oocytes were then washed 3 times in the cor-
responding handling medium without CLC. Oocytes were then vitrified/warmed as previously
described using a FCS-supplemented medium (group A) or a synthetic medium containing
6% PVP and 1 mg/ml fetuin (groups B to E). After warming, oocytes were allowed to recover
for 2 additional hours in IVM medium. Oocytes in vitro matured for 24 h were used as non-
vitrified controls.
After 24 h of IVM, oocytes from each treatment group were in vitro fertilized and cultured.
Cleavage rates were determined 48 hpi and blastocyst rates on Days 7 and 8 pi (8 replicates per
group).
Experiment 2. Cholesterol tracking in living oocytes treated with different CLC concen-
trations and effects on embryo developmental competence after vitrification/warming
Experiment 2a: Live-cell imaging of cholesterol transport into in vitro matured bovine
oocytes incubated with different CLC concentrations.
After 22 h in IVM, oocytes were denuded by gentle pipetting and incubated with 1 mg/ml,
2 mg/ml or 3 mg/ml BODIPY-labeled CLC in HEPES-buffered TCM-199 containing 10% (v/
v) FCS at 38.5˚C. BPY-Chol fluorescence was visualized in living oocytes using a confocal
microscope at 10, 20, 30, 40 and 60 min. A total of 30 oocytes were examined in each group in
3 different replicates.
Experiment 2b: Effects of different CLC concentrations prior to vitrification on the devel-
opmental competence of in vitro matured bovine oocytes
After 22 h of in vitro maturation and according to the results obtained in Experiment 2a,
oocytes were randomly distributed into 4 groups: Control Vit group = no CLC treatment;
Table 1. Primers used for reverse transcription–quantitative polymerase chain reaction.
Gene Primer sequence Fragment size GenBank accession no. Sequence references
DNMT3A F: CCGTAGTGTCCAAGACCAATC
R: GCTGAGGCAAATCCTCGTAAC
186 BC114063 [20]
HSPA1A F: AAGGTG CTGGACAAGTGCCAGGAGGTGA
R: ACTTGGAAGTAAACAGAAACG GGTGAAAA
503 U09861 [21]
UBE2A F: GGGCTCCGTCTGAGAACAACATC
R: CATACTCCCGCTTGTTCTCCTGG
336 XM_864331 [22]
CYP51 F: GCTCATTAGTTTGGGGGTGA
R: TCCCCACCCATCCTTACATA
218 NM_001025319.2 [22]
IGF2R F: CAGGTCTTGCAACTGGTGTATGA
R: TTGTCCAGGGAGATCAGCATG
137 J03527 [23]
BAX F: TCTGACGGCAACTTCAACTG
R: TGGGTGTCCCAAAGTAGGAG
214 NM_173894.1 [24]
MnSOD F: CCC ATGAAGCCCTTTCTAATCCTG
R: TTCAGAGGCGCTACTATTTCCTTC
307 L22092.1 [21]
CHUK F: TGATGGAATCTCTGGAACAGCG
R: TGCTTACAGCCCAACAACTTGC
180 NM_174021.2 [25]
Abbreviations: F, forward; R, reverse
https://doi.org/10.1371/journal.pone.0184714.t001
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CLC 1 mg/ml 40’ group = oocytes incubated with 1 mg/ml CLC for 40 min; CLC 2 mg/ml 30’
group = oocytes incubated with 2 mg/ml CLC for 30 min; CLC 3 mg/ml 20’ group = oocytes
incubated with 3 mg/ml CLC for 20 min. Oocytes were then washed 3 times in a medium with-
out CLC and vitrified/warmed as previously described but using media supplemented with
FCS. After warming, oocytes were allowed to recover for 2 additional hours in IVM medium.
Oocytes in vitro matured for 24 h were used as non-vitrified controls.
After 24 h of IVM, oocytes from each treatment group were in vitro fertilized and cultured.
Cleavage rates were determined 48 hpi and blastocyst rates on Days 7 and 8 pi (4 replicates per
group).
Experiment 3. Effects of CLC treatment before vitrification of immature and in vitro
matured oocytes on developmental competence and specific gene expression.
After follicle aspiration, a proportion of the COCs was randomly divided into the following
groups: GV-VIT = vitrified GV oocytes; and GV-CLC-VIT = GV oocytes incubated with 2
mg/ml CLC for 30 min and vitrified. After vitrification, VIT group oocytes were warmed and
transferred back to the maturation medium.
The rest of the COCs were matured in vitro for 22 h and randomly divided into three
groups: Control = fresh non-vitrified MII oocytes; MII-VIT = vitrified MII oocytes; and
MII-CLC-VIT = MII oocytes incubated with 2 mg/ml CLC for 30 min and vitrified. After
vitrification, VIT group oocytes were warmed and transferred back to the maturation
medium. After 24 h of IVM, oocytes from each treatment group were in vitro fertilized and
cultured as previously described. In a first set of experiments (5 replicates), embryo develop-
ment was allowed to continue until Day 5 when morulae from the different treatment
groups were harvested for RNA extraction and RT-qPCR. In a second set of experiments,
cleavage rates were determined 48 hpi and blastocyst rates on Days 7 and 8 pi (6 replicates
per group)
Statistical analysis
All statistical tests were performed using the software package SPSS version 21.0 for Windows
(IBM Corp.; Chicago, Illinois, USA). Data are provided as the mean ± standard error of the
mean (SEM) and significance was set at P 0.05. The Shapiro-Wilk and Levene tests were
used to check the normality of data and homogeneity of variances, respectively.
On the one hand, the effects of CLC, handling medium and vitrification medium on the
development competence of in vitro matured and fertilized bovine oocytes were tested through
a three-way analysis of variance followed by post-hoc Sidak’s test. The effects of CLC treatment
of in vitro matured bovine oocytes in an FCS-supplemented or chemically-defined medium
before vitrification on the developmental competence of embryos derived from these oocytes
were evaluated through one-way ANOVA, followed by post-hoc Sidak’s test. Embryo develop-
mental competence of immature and in vitro-matured bovine oocytes pretreated with CLC
before vitrification was evaluated through a two-way ANOVA (factors: stage and treatment)
followed by post-hoc Sidak’s test.
With regard to analysis of gene expression, relative expression of six out of seven genes (all
except CYP51) did not match with parametric assumptions. For this reason, we attempted to
transform our data through square root (
p
x) or arcsin square root (arcsin
p
x). Transforma-
tion was only successful in the case of arcsin
p
(IGF2R). Therefore, the effects of treatment (i.e.
fresh, vitrified-warmed control, vitrified-warmed + CLC) and stage (GV, MII) upon the
expression of CYP51 and IGF2R were tested through a two-way analysis of variance (ANOVA)
followed by Sidak’s test for pair-wise comparisons. For the relative transcript abundance of the
other genes (DNMT3, HSPA1A, MnSOD, BAX and UBE2A), we performed a non-parametric
Cholesterol treatment before bovine oocyte vitrification
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Scheirer-Ray-Hare ANOVA for ranked data (again, factors were treatment and stage). Follow-
ing calculation of the ‘H’ statistic, the Mann-Whitney test was run for pair-wise comparisons.
Results
Experiment 1
Characterize the effects of CLC added to a FCS-supplemented or chemically-defined medium
before vitrification on in vitro matured bovine oocytes.
Experiment 1a. Live-cell imaging of cholesterol transport within in vitro matured bovine
oocytes incubated with CLC in a FCS-supplemented or chemically-defined medium.
To examine whether cholesterol in a medium supplemented with FCS was transported into
the oocyte, cholesterol internalization at different chase times was imaged in living bovine
oocytes incubated with 2 mg/ml CLC in a medium containing FCS (Fig 1A) or PVA (Fig 1B).
After 30 min of incubation, the plasma membrane showed a high labeling intensity relative to
the cytoplasm. As chase time lengthened, cholesterol inclusion in the cytoplasm also increased
considerably. After 75 min, cholesterol trafficking through the plasma membrane into the
cytoplasm showed the same pattern when the medium was supplemented with FCS or with
PVA.
Experiment 1b. Effects of CLC added to FCS-supplemented or chemically-defined
medium before vitrification on the developmental competence of IVM oocytes
Given that cholesterol labeling could be observed at the plasma membrane after 30 min of
incubation in the previous experiments, in vitro matured oocytes were vitrified/warmed fol-
lowing pre-treatment with 2 mg/ml CLC for 30 min in a FCS- or PVA-supplemented medium.
The vitrification medium used for this experiment was supplemented with PVP and fetuin to
avoid the use of FCS during the vitrification process. Table 2 shows the results of oocyte sur-
vival and embryo development after oocytes were subjected to each treatment. Significantly
higher survival, cleavage and blastocyst rates were observed for non-vitrified oocytes than vitri-
fied oocytes regardless of CLC treatment or the holding medium used. When comparing the
vitrification groups, oocytes from group C, held in FCS-supplemented medium before vitrifi-
cation in synthetic medium showed a significantly lower survival rate compared to the other
vitrification groups. Oocytes from group C also showed significantly lower cleavage rates
when compared to the group of oocytes held and vitrified in media containing FCS (group A)
while no significant differences were observed for oocytes in groups B, D and E when com-
pared to groups A and C. No significant differences in Day 7-blastocyst rates were observed
among the vitrification groups. However, oocytes from group D showed significantly lower
Day 8-blastocysts rate than oocytes from group A. When evaluating embryo expansion as an
indicator of embryo quality, CLC pretreatment of oocytes in the presence of PVA (group D)
resulted in significantly reduced expansion rates on Day 8 pi when compared to those
recorded in fresh non-vitrified oocytes, while the remaining vitrification groups showed simi-
lar rates of expansion to the control and D groups. Only embryos derived from oocytes from
group A (held and vitrified in media supplemented with FCS) were able to hatch, although no
significant differences in rates were observed between this group and the remaining vitrifica-
tion groups.
Experiment 2
Cholesterol tracking in living bovine oocytes treated with different CLC concentrations and
effect on embryo development competence after vitrification/warming
Experiment 2a. Live-cell imaging of cholesterol transport into in vitro matured bovine
oocytes incubated with different CLC concentrations.
Cholesterol treatment before bovine oocyte vitrification
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Fig 1. Subcellular localization of BPY-Chol in in vitro matured bovine oocytes. Fluorescence intensity observed at
the membrane and in the cytoplasm of bovine oocytes treated with 2 mg/ml CLC in a medium containing FCS or PVA at
different chase times: 30, 45, 60 and 75 minutes. Mean ± SEM values for each subcellular compartment over time.
https://doi.org/10.1371/journal.pone.0184714.g001
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Internalization of fluorescence-labeled cholesterol was followed by confocal microscopy
imaging of living bovine oocytes incubated with 1 mg/ml (Fig 2A), 2 mg/ml (Fig 2B) or 3 mg/
ml CLC (Fig 2C) at different chase times. As in the previous experiment, total cell fluorescence
increased with incubation time. When oocytes incubated with 2 mg/ml or 3 mg/ml CLC were
imaged after 10 min, intense labeling was observed at the plasma membrane while there was
essentially no labeling in the cytoplasm. This pattern was repeated when the incubation time
was extended to 20 min in the presence of 1 mg/ml CLC. For the highest CLC concentration
(3 mg/ml), fluorescence could be observed diffusing into the cytoplasm as early as 20 min,
while for 1 mg/ml CLC and 2 mg/ml CLC, 40 and 30 min respectively were required before
fluorescence spread into the cytoplasm. Fluorescence intensity in the cytoplasm increased with
incubation time and higher levels of fluorescence were observed for oocytes incubated with
the highest CLC concentrations (2 and 3 mg/ml). Images of cholesterol internalization into the
oocytes are provided in Fig 3.
Experiment 2b. Effects of different CLC concentrations prior to vitrification on the devel-
opmental competence of in vitro matured bovine oocytes.
To select the incubation time and CLC concentration for this experiment we looked for
high fluorescence intensity at the plasma membrane level along with some scattered fluores-
cence in the cytoplasm (<25%). This level of fluorescence indicated that the plasma membrane
contained relatively high amount of CLC and that the low diffusion of CLC into the cytoplasm
would not be likely to impair oocyte survival after vitrification. Thus, based on the results
obtained in Experiment 2a and these fluorescence criteria, we tested different incubation times
and concentrations of CLC prior to vitrification of in vitro matured oocytes to assess their
effects on early in vitro embryo development (Table 3). While differences among treatments
were not observed in terms of survival rates, cleavage rates were significantly reduced in the
groups of oocytes treated with 1 mg/m CLC for 20 min or 2 mg/ml for 30 min when compared
with control fresh oocytes, while this was not observed in the remaining vitrification groups.
Day 7 and Day 8 blastocyst yields were significantly higher for fresh non-vitrified oocytes
when compared to the vitrified oocytes. Among the vitrification groups, no significant differ-
ences in Day 7 and Day 8 blastocyst yields were observed, regardless of the concentration or
incubation time.
Table 2. Effect of CLC treatment of in vitro matured bovine oocytes in an FCS-supplemented or chemically-defined medium before vitrification on
the developmental competence of embryos derived from these oocytes.
CLC Handling
medium
Vit
medium
n Mean % ± SEM Day 8 embryo
Mean % ± SEM
Survival Cleavage Blastocyst
Day 7
Blastocyst
Day 8
Non-
expanded
Expanded Hatched
Control - FCS - 552 95.7 ± 1.6 a 75.1 ± 2.6 a 19.8 ± 1.9 a 22.0 ± 1.8 a 21.3 ± 4.2 a 58.8 ± 5.0 a 19.9 ± 4.8a
A - FCS FCS 383 71.6 ± 3.2 b 44.4 ± 2.7 b 4.3 ± 1.0 b 7.2 ±1.0 b 64.9 ± 10.0 b 31.5 ± 9.5 ab 3.6 ± 3.6 b
B + FCS PVP+ F 121 60.6 ± 12.3 b 31.5 ± 8.5 bc 3.1 ± 1.3 b 5.5 ± 2.5 bc 33.3 ± 19.2 ab 66.7 ± 19.2 ab 0 b
C - FCS PVP+ F 109 49.7 ± 2.8 c 24.8 ± 3.7 c 2.6 ± 1.7b 4.6 ± 2.2 bc 55.6 ± 29.4 ab 44.4 ± 29.4 ab 0 b
D + PVA PVP+ F 186 66.0 ± 5.5 b 37.4 ± 4.0 bc 2.6 ± 1.0 b 3.5 ± 1.0 c 90.0± 10.0b 10.0±10.0 b 0 b
E - PVA PVP+ F 293 64.0± 5.3 b 34.6 ± 3.1 bc 2.7 ± 0.7 b 5.9 ± 0.9 bc 68.5± 10.2b 31.5±10.2 ab 0 b
CLC treatment: oocytes were incubated with 2 mg/ml CLC for 30 min. Handling medium: the handling medium used during CLC incubation contained PVA
or FCS. Vit medium: vitrification/warming medium contained FCS or PVP+Fetuin. Data are provided as the mean ± SEM (standard error of the mean).
a Values with different subscripts within columns differ significantly (P<0.05).
b Values with different subscripts within columns differ significantly (P<0.05).
c Values with different subscripts within columns differ significantly (P<0.05).
https://doi.org/10.1371/journal.pone.0184714.t002
Cholesterol treatment before bovine oocyte vitrification
PLOS ONE | https://doi.org/10.1371/journal.pone.0184714 September 14, 2017 10 / 21
Fig 2. Subcellular localization of BPY-Chol in in vitro matured bovine oocytes incubated with CLC.
Fluorescence intensity observed at the plasma membrane and in the cytoplasm of bovine oocytes treated
with 1, 2 or 3 mg/ml CLC at different chase times: 10, 20, 30, 40 and 60 minutes. Mean ± SEM values for each
subcellular compartment over time.
https://doi.org/10.1371/journal.pone.0184714.g002
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Fig 3. Immunofluorescence localization of BODIPY-cholesterol in in vitro matured oocytes. The plasma membrane and cytoplasm localization of
cholesterol was detected using the BODIPY fluorescent probe in in vitro matured bovine oocytes incubated with different concentrations of CLC. (A-C)
oocytes incubated with 1 mg/ml of CLC imaged at 20, 40 and 60 minutes; (D-F) oocytes incubated with 2 mg/ml of CLC imaged at 30, 40 and 60 minutes;
(G-I) oocytes incubated with 3 mg/ml of CLC imaged at 10, 20 and 40 minutes. BPY-Chol could be detected only at the plasma membrane (A, G), at the
plasma membrane and diffusing into the cytoplasm (B,D,H) or at the plasma membrane and mostly distributed in the cytoplasm (E,C,F,I). Fluorescence
intensity was quantified using ImageJ software. Scale bar = 30 μm.
https://doi.org/10.1371/journal.pone.0184714.g003
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Experiment 3
Effects of CLC treatment before vitrification of immature and in vitro matured oocytes on
developmental competence and specific gene expression.
Table 4 shows the in vitro embryo developmental competence of oocytes –immature or in
vitro-matured—pretreated with 2 mg/ml CLC for 30 min prior to vitrification. All vitrifica-
tion treatments led to significantly lower percentages of embryo cleavage and Day 7 or Day 8
blastocyst yields (P<0.05) compared to fresh non-vitrified oocytes. Cleavage and blastocyst
rates were similar for all vitrified/warmed oocytes, regardless of CLC treatment or nuclear
stage. Furthermore, all vitrified oocyte groups returned similar rates of blastocyst expansion
to the control fresh oocyte group except for a significantly higher percentage observed for
the vitrified MII oocytes. Only matured MII oocytes treated with CLC before vitrification
also demonstrated similar percentages of blastocyst hatching to control fresh oocytes,
Table 3. Comparison of different incubation times and concentrations of CLC prior to vitrification on the developmental competence of in vitro-
matured bovine oocytes.
Treatment n Mean % ± SEM Day 8 embryos
Mean % ± SEM
Survival Cleavage Blastocysts Day 7 Blastocysts Day 8 Non-expanded Expanded Hatched
Control 191 91.9 ± 5.7 62.4 ± 4.7 a 15.9 ± 1.6 a 18.7 ± 0.1a 36.0 ± 22.4a 50.4 ± 16.8 13.6 ± 8.2
Control Vit 101 80.2 ± 0.2 48.4 ± 6.7 ab 7.1 ± 1.4b 8.8 ± 1.1b 33.3 ± 19.2a 66.7 ±19.2 0
CLC 1 mg/ml 40’ 107 80.5 ± 5.3 33.6 ± 1.9 b 2.0 ± 1.2b 5.0 ± 1.4b 75.0 ± 25.0b 25.0 ± 25.0 0
CLC 2 mg/ml 30’ 114 80.5 ± 4.9 37.1 ± 6.8 b 5.7 ± 3.2b 8.4 ± 1.8b 63.9 ± 21.7a, c 36.1 ± 21.7 0
CLC 3 mg/ml 20’ 101 80.8 ± 13.7 51.0 ± 13.0 ab 6.0 ± 2.2b 7.4 ± 2.0b 72.2 ± 14.7b, c 27.8 ±14.7 0
Treatments: Control = oocytes in vitro matured for 24 h; Control Vit: no CLC treatment before vitrification; CLC 1 mg/ml 40’ = oocytes incubated with 1mg/ml
CLC for 40 min before vitrification; CLC 2 mg/ml 30’ = oocytes incubated with 2 mg/ml CLC for 30 min before vitrification; CLC 3 mg/ml 20’ = oocytes
incubated with 3 mg/ml CLC for 20 min before vitrification. Data are provided as the mean ± SEM.
a Values with different subscripts within columns differ significantly (P<0.05).
b Values with different subscripts within columns differ significantly (P<0.05).
c Values with different subscripts within columns differ significantly (P<0.05).
https://doi.org/10.1371/journal.pone.0184714.t003
Table 4. Embryo developmental competence of immature and in vitro-matured bovine oocytes pretreated with CLC before vitrification.
Treatment n Mean % ± SEM Day 8 embryos
Mean % ± SEM
Survival Cleavage Blastocyst Day 7 Blastocyst Day 8 Non-expanded Expanded Hatched
Control 185 93.4 ± 4.3a 66.7 ± 3.6a 18.4 ± 1.6 a 19.4 ± 0.8 a 42.6 ± 10.9 a 35.6 ±10.2 a 21.8 ± 10.0 a
GV-VIT 238 72.0 ± 7.2ab 41.4 ±5.5b 5.6 ± 1.1b 7.3 ± 0.8 b 66.7 ±16.7ab 27.8 ± 12.7 a 5.6 ± 5.6 b
GV- CLC-VIT 236 64.0 ± 4.9 b 40.9 ± 4.8b 5.8 ± 0.7b 5.7 ± 1.5 b 75.00 ±11.2b 25.0 ±11.2 a 0.0 ± 0.0 b
MII-VIT 180 60.8 ± 10.0 b 39.9 ± 5.5b 7.3 ±2.1b 7.0 ± 1.3 b 38.9 ± 15.3 a 61.1 ± 15.3 b 0.0 ± 0.0b
MII-CLC-VIT 206 69.0 ± 5.1 b 41.7 ±2.2b 8.9 ± 1.3b 9.9 ± 1.7 b 36.1 ± 15.8 a 55.6 ±13.4 ab 8.3 ± 5.7ab
Treatments: Control = fresh non-vitrified MII oocytes; GV VIT = vitrified GV oocytes; GV-CLC-VIT = GV oocytes vitrified after 30 min incubation with 2 mg/ml
CLC; MII VIT = vitrified MII oocytes; MII-CLC-VIT = MII oocytes vitrified after 30 min incubation with 2 mg/ml CLC. Data are provided as the mean ± SEM.
a Values with different subscripts within columns differ significantly (P<0.05).
b Values with different subscripts within columns differ significantly (P<0.05).
c Values with different subscripts within columns differ significantly (P<0.05).
https://doi.org/10.1371/journal.pone.0184714.t004
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although rates did not differ statistically from those observed in the other vitrification
groups.
In order to determine whether changes in the expression of developmentally-important
genes were associated with the different vitrification protocols, we next evaluated the levels of
DNMT3A,HSPA1A, MnSOD, BAX, CYP51, IGF2R, UBE2AmRNAs in vitro produced morulae
(Fig 4). No significant differences were detected in relative mRNA abundances for HSPA1A,
MnSOD and IGF2R in morulae derived from GV vitrified oocytes or MII vitrified oocytes
compared to non-vitrified oocytes, regardless of CLC treatment. DNMT3A and BAX gene
expression was significantly higher in morulae from vitrified GV oocytes. The expression of
both genes in CLC-treated vitrified GV oocytes remained similar when compared to the levels
observed in non-vitrified fresh oocytes. In contrast, CYP51 expression was significantly lower
in morulae from vitrified GV oocytes compared to morulae from CLC-treated vitrified or
non-vitrified oocytes. While the expression of the BAX gene in vitrified MII oocytes remained
similar to that in the fresh oocyte control group regardless of CLC treatment, DNMT3A
expression was significantly higher in morulae from vitrified MII oocytes, and no differences
were observed in morulae from oocytes vitrified after CLC treatment. UBE2A gene expression
was significantly lower in morulae from GV- or MII vitrified or MII-CLC-vitrified oocytes,
while expression levels of this gene in morulae derived from GV-CLC-vitrified oocytes
remained similar to those recorded in control fresh oocytes.
Discussion
Cryopreserved oocytes show highly compromised survival and developmental capacities due
to the morphological and cytological damage induced by the cryopreservation process. Cells
with more flexible membranes that are more permeable to water and intracellular cryoprotec-
tants are known to incur less damage during cryopreservation [26]. Adding cholesterol to the
incubation medium increases membrane fluidity at lower temperatures by modifying how
membrane phospholipids interact with each other, making membranes less contracted at
lower temperatures [27].
Horvath and Seidel [8] detected no effects of pre-treatment of in vitro mature bovine
oocytes with CLC in the presence of FCS before vitrification on subsequent embryo develop-
mental competence. In contrast, when a synthetic medium was used during CLC treatment
(2 mg/ml CLC for 1 h), cleavage and development up to eight-cell embryo rates were signifi-
cantly higher for oocytes pretreated with CLC prior to vitrification. These authors attributed
the lack of effect of CLC treatment in improving cryotolerance that cholesterol was preferen-
tially transferred to lipids or proteins present in the fetal calf serum (FCS) avoiding its incor-
poration into the oocyte [8]. In the present study, through in vivo confocal microscopy and
BPY-Chol labeling, we observed cholesterol trafficking into oocytes at a specific CLC con-
centration (2 mg/ml) using a handling medium supplemented either with FCS or PVA.
Moreover, in both the FCS and PVA supplemented media, CLC was observed at the plasma
membrane 30 min after incubation. Based on these results, we compared the effect on
embryo development of CLC treatment (2 mg/ml for 30 min) prior to vitrification using the
two supplements. Our results showed that neither prior CLC treatment, nor the use of FCS
or PVA, conferred any benefits in terms of embryo development up to the blastocyst stage. It
has been shown that both cholesterol depletion and cholesterol enrichment of the plasma
membrane may affect cellular functions [28]. In our study, we postulate that any improve-
ments attributable to plasma membrane cholesterol enrichment may have been offset by cell
alterations resulting from changes in phospholipid distributions and modified cholesterol
distribution among the cell compartments due to the presence of CLC [28–30]. This may
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Fig 4. Relative expression levels of the genes DNMT3 (A), HSPA1A (B), MnSOD (C), BAX (D), CYP51 (E),
IGF2R (F), UBE2A (G) recorded in in vitro produced morulae. GV = oocytes at the germinal vesicle stage;
MII = oocytes at the metaphase II stage; Control = fresh, non-vitrified oocytes; Vit = vitrified oocytes; CLC
+Vit = Oocytes pre-treated with 2 mg/ml CLC for 30 min and vitrified. Data are provided as the mean ± SEM. Different
subscripts indicate significant differences (P<0.05) in gene expression.
https://doi.org/10.1371/journal.pone.0184714.g004
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have had an effect on the oocyte plasma membrane and on the subsequent developmental
competence of the oocyte after vitrification.
The results obtained in this study for the use of FCS or synthetic macromolecular compo-
nents in the vitrification solution are comparable to those of other studies examining small vol-
ume supports for vitrification [17, 31, 32]. The solutions used for oocyte in vitro maturation,
handling, vitrification or warming usually contain FCS [17, 31, 33–35]. Since we observed no
improvement in embryo developmental competence after the vitrification of oocytes handled
or vitrified in synthetic media, FCS was used as a supplement for the rest of our experiments.
It has been already reported that the efficiency of cholesterol transfer from βCD inclusion
complexes to biological membranes depends on βCD-cholesterol concentration and exposure
duration [5, 36, 37]. Because no differences in embryo development were observed here after
incubation with 2mg/ml CLC for 30 min we used confocal microscopy to identify the time-
point at which fluorescent-tagged cholesterol was primarily located at the plasma membrane
using three different concentrations of CLC: 40 min for 1 mg/ml, 30 min for 2 mg/ml and 20
min for 3 mg/ml. Cholesterol manipulation as carried out in this study may have modified the
plasma membrane properties of matured oocytes pre-treated with different CLC concentra-
tions for varying time intervals. However, we observed no correlation between oocyte cryoto-
lerance and embryo cleavage or embryo development up to the blastocyst stage. The effects of
cholesterol on membranes depend on lipid composition and fatty acid saturation. Cholesterol
and sphingomyelin are thought to form ordered lipid domains (rafts) in mammalian cell
membranes [28]. Cholesterol disrupts the highly ordered gel phase of brain sphingomyelin,
leading to a more fluid membrane, while reducing the fluidity of brain phosphatidylcholine
bilayers [38]. We propose that the irregular incorporation of labeled lipids into the different
cholesterol domains of the oocyte plasma membrane may preclude increases in membrane flu-
idity in response to the addition of cholesterol.
Cryobiological differences between immature and in vitro matured oocytes prompted our
subsequent studies in which oocytes at the GV or MII stage were pretreated with 2 mg/ml
CLC for 30 min before vitrification, after which the impact on embryo development and gene
expression was determined. Although no differences in cleavage and blastocyst yields were
observed after CLC treatment, differences were detected in the relative abundance of some
gene transcripts during early embryo development. For example, the relative abundance of
DNMT3A transcripts in morulae derived from immature and in vitro matured vitrified oocytes
was significantly higher compared to abundances observed in morulae derived from fresh
oocytes. Similarly, Shirazi et al. [39] found that the overall expression of DNMT3B in morulae
derived from vitrified immature ovine oocytes was greater than in morulae derived from non-
vitrified fresh oocytes. DNMT3A and DNMT3B drive most de novo methylation during embry-
onic reprogramming whereby methyl groups are added to previously unmodified DNA [40].
DNA methylation exerts essential functions in many genetic processes such as X chromosome
inactivation, genome imprinting, and transcriptional silencing of specific genes and repetitive
elements [41, 42]. Given its role in de novo methylation, abnormal levels of DNMT3A expres-
sion could suggest that embryos derived from vitrified oocytes are at higher risk for problems
in these processes, which could be ameliorated by CLC treatment prior to vitrification. Impor-
tantly, CLC treatment prior to vitrification of both GV and MII bovine oocytes gave rise to
morulae showing levels of DNMT3A transcripts approaching those of morulae derived from
non-vitrified oocytes. Similarly, when the expression of UBE2A, another gene related to devel-
opmental epigenetics, was analyzed, morulae derived from GV vitrified after CLC treatment
showed similar expression levels to those derived from non-vitrified oocytes. Further work is
needed to assess global levels of DNA methylation and histone acetylation in oocytes pre-
treated with CLC prior to vitrification.
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The expression of BAX was also significantly higher in morulae derived from vitrified GV
oocytes than morulae derived from fresh or CLC-treated GV oocytes. When BAX is overex-
pressed in cells, apoptotic death is accelerated and previous research has shown that morpho-
logically poor quality or fragmented embryos show higher expression levels of this gene [43,
44]. In response to pre-treatment with CLC before vitrification of GV oocytes, BAX gene
expression levels returned to similar levels to those observed in fresh control oocytes. This sug-
gests that CLC may have helped improve the quality of embryos obtained after oocyte vitrifica-
tion. CYP51 (cytochrome P450 family 51 or lanosterol 14a-demethylase CYP51) is required for
de novo cholesterol synthesis during embryogenesis, which is essential for the regulation of
membrane fluidity and thereby related to survival after embryo vitrification. Because blastocyst
quality correlates positively with embryo survival after vitrification [45, 46], CLC treatment
before vitrification of GV oocytes may also have served to improve embryo quality after vitrifi-
cation of GV oocytes. While CYP51 gene expression was significantly lower in morulae derived
from vitrified GV oocytes, morulae derived from GV-CLC vitrified oocytes showed similar rel-
ative abundances of mRNA transcripts to morulae derived from fresh non-vitrified oocytes.
Embryos also show changes in expression of genes reflecting the stress response to subopti-
mal conditions [21]. Differences in gene transcript levels between morulae derived from vitri-
fied oocytes treated with CLC compared to those without were higher for immature oocytes.
This suggests that vitrification at the GV stage may be particularly harmful for the oocyte and
that treatment with 2 mg/ml CLC for 30 min may protect the oocyte from specific stresses, giv-
ing rise to pre-embryos of higher developmental potential. Even though differences in devel-
opmental competence in terms of blastocyst rates were not observed after CLC treatment,
differences in the relative abundances of some gene transcripts important for early embryo
development were detected. Differences in the effects of CLC treatment between GV and MII
oocytes might be related to their different cryotolerances,. For example, hydraulic conductivity
is 2-fold lower in GV oocytes compared to MII oocytes [47, 48]. Thus, MII stage bovine
oocytes have higher water and CPA permeability coefficients than GV stage oocytes [47, 48].
This implies that GV oocytes are less able to tolerate water flux or shear force related damage
during volume changes [49]. Accordingly, GV oocytes may benifit more from membrane cho-
lesterol enrichment through CLC treatment. Since membranes are stabilized by cholesterol
and remain more fluid at lower temperatures, stresses associated with membrane distortion
due to dehydration and shrinkage during vitrification, especially damaging for GV stage
oocytes, are likely to be be reduced [50].
In conclusion, CLC pre-treatment before the vitrification of bovine in vitro matured oocytes
does not appear to affect subsequent cleavage and embryo development rates, irrespective of
the presence of FCS in the handling medium, the CLC concentration, incubation time or mei-
otic oocyte stage (GV or MII). However, relative differences in the expression of genes related
to embryo development in oocytes pretreated with 2 mg/ml suggests that CLC does improve
some aspects of embryo quality after vitrification, particularly when derived from oocytes vitri-
fied at the GV stage. Further studies will obviously be necessary to determine whether the
changes in gene expression that we have identified, and the processes in which they participate,
can be further enhanced to optimize oocyte quality after vitrification.
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